Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Syngenta Lawsuits Over Viptera, Duracade Corn Seed Allowed to Move Forward September 24, 2015 Irvin Jackson Add Your Comments A federal judge has issued a ruling that will allow hundreds of Syngenta corn seed lawsuits to move forward, rejecting calls by the agricultural company to throw out claims brought by farmers and others in the industry over the company’s Viptera and Duracade genetically modified seed. Syngenta currently faces about 380 lawsuits over Viptera and Duracade products, involving claims on behalf of thousands of individuals impacted by drops in corn prices allegedly caused by the company’s sale of genetically modified seed without first obtaining approval for the corn to be exported to China, which is one of the largest markets for U.S. corn. In a memorandum and order (PDF) issued earlier this month, U.S. District Judge John W. Lungstrum denied a request by Syngenta to dismiss the lawsuits, which will allow the litigation to move forward. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION While China recently approved the genetic trait produced by Syngenta’s Agisure Viptera and Agisure Duracade corn seeds, also known as MIR162, farmers and agricultural companies maintain that they have suffered significant economic harm over the past year, due to drops in corn prices when China rejected any imports with traces of MIR162, which widely contaminated the entire U.S. corn supply. Farmers and others in the industry estimate that $1 billion in damages have been caused by the GMO corn seed, since corn products grown at many different farms are commonly co-mingling, and Syngenta also recommended that Agisure Viptera and Duracade seed be grown next to other corn, causing cross-pollination. In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) decided to centalize all Syngenta GMO corn lawsuits before Judge Lungstrum for pretrial proceedings in the District of Kansas. Following the coordinated pretrial proceedings, if Syngenta corn seed settlements are not reached to resolve the litigation, individual cases may be remanded back to the U.S. District Courts where they were originally filed for separate trials across the country. Judge Upholds Claims Syngenta Had Duty To Protect Farmers Syngenta argued that it was not required to protect U.S. farmers and that their claims that the company should have taken “reasonable care” are too broad. It also attacked the lawsuits on a variety of state and federal specifics, some of which Judge Lungstrum upheld. However, he generally allowed the lawsuits to go forward and told plaintiffs affected by some of the rejected portions of the lawsuits that they could refile amended complaints. “As alleged by plaintiffs (which allegations must be accepted at this stage), plaintiffs’ particular injuries were not only foreseeable, they were actually foreseen by Syngenta, with plaintiffs suffering the very harm expected to occur,” Judge Lungstrum wrote in the 120 page memorandum explaining the ruling. “That foreseen harm applied to the industry generally, and thus plaintiffs’ injury is sufficiently connected to Syngenta’s conduct and is not wholly out of proportion to Syngenta’s culpability.” Syngenta first allegedly asked China for approval of Viptera corn seed back in 2010, according to allegations raised in lawsuits, but began selling the corn to farmers and other agribusiness companies, claiming approval was imminent. However, China did not approve the trait until late last year, blocking all imports of corn with traces of MIR162 trait since at least November 2013. Even farmers who did not purchase or use Syngenta corn seed may have claims against the company for damages associated with bans on shipments containing their corn, which were contaminated with the trait. On December 22, Syngenta announced that China had finally approved MIR162 for shipping to that market, but by then many farmers claim to have already suffered severe economic damage due to the price drops that resulted from an approval delay which they say Syngenta led them to believe was not going to occur. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Corn, Corn Seed, Genetically Modified Organisms, GMO, Syngenta, Viptera More Syngenta Corn Lawsuit Stories Syngenta Corn Seed Settlement to Result in $1.4B in Payments to U.S. Farmers September 27, 2017 Syngenta Corn Seed Lawsuit Results in $218 Million Verdict for Farmers June 26, 2017 More than 1,300 Syngenta Farmer Claims Being Pursued Over Genetically Modified Corn Seed January 29, 2015 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: yesterday) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025) Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: 2 days ago) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025) Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 5 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)
More than 1,300 Syngenta Farmer Claims Being Pursued Over Genetically Modified Corn Seed January 29, 2015
Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: yesterday) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025)
Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: 2 days ago) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)
Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 5 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)